title: Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging.
abstract: The overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is a common underlying mechanism of many neuropathologies, as they have been shown to damage various cellular components, including proteins, lipids and DNA. Free radicals, especially superoxide (O(2)*-), and non-radicals, such as hydrogen peroxide (H(2)O(2)), can be generated in quantities large enough to overwhelm endogenous protective enzyme systems, such as superoxide dismutase (SOD) and reduced glutathione (GSH). Here we review the mechanisms of ROS and RNS production, and their roles in ischemia, traumatic brain injury and aging. In particular, we discuss several acute and chronic pharmacological therapies that have been extensively studied in order to reduce ROS/RNS loads in cells and the subsequent oxidative stress, so-called "free-radical scavengers." Although the overall aim has been to counteract the detrimental effects of ROS/RNS in these pathologies, success has been limited, especially in human clinical studies. This review highlights some of the recent successes and failures in animal and human studies by attempting to link a compound's chemical structure with its efficacy as a free radical scavenger. In particular, we demonstrate how antioxidants derived from natural products, as well as long-term dietary alterations, may prove to be effective scavengers of ROS and RNS.
authors.affiliation: Department of Biology, University of Prince Edward Island, Charlottetown, PE, Canada.
authors.forename: J E
authors.initials: JE
authors.lastname: Slemmer
authors.forename: J J
authors.initials: JJ
authors.lastname: Shacka
authors.forename: M I
authors.initials: MI
authors.lastname: Sweeney
authors.forename: J T
authors.initials: JT
authors.lastname: Weber
mesh_terms: D000375:Aging / Q000187:drug effects*; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001930:Brain Injuries / Q000188:drug therapy*; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species / Q000378:metabolism; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism
chemical_list: D000975:Antioxidants; D016166:Free Radical Scavengers; D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species